measles
MEASLES
Measles, also known as rubeola, is a highly contagious disease caused by the measles virus Morbillivirus.
It is characterized by generalized maculopapular rash, fever, cough, rhinitis and conjunctivitis. Transmission is through respiratory tract or conjunctivae following contact with droplet aerosols.
It is highly communicable from 4 days before the rash up to 4 days after its onset.
The incubation period from exposure to prodrome averages 7-21 days.

Measles Treatment

Supportive Therapy

  • Patients are provided w/ supportive care

Oxygen Therapy

  • May be given in patients w/ resp tract involvement

Hydration & Nutrition

  • Oral rehydration is effective in majority of cases
  • Administer IV fluids, if necessary

Antipyretics

  • May be used to relieve fever

Vitamin A

  • Recommended in the following patients w/ measles:
    • Hospitalized patients 6 mth-2 yr of age w/ complications
    • Patients >6 mth who have not received vitamin A supplementation & who have any of the following risk factors: Vitamin A deficiency, immunodeficient state, impaired intestinal absorption, moderate to severe malnutrition, travel history to areas where high mortality rates are attributed to measles
  • May be taken as single dose of 50,000 IU PO for patients <6 mth, 100,000 IU PO for patients 6-11 mth or 200,000 IU PO for ≥1 yr of age
  • Dose is repeated the next day & 4 wk later esp in patients w/ ophthalmologic evidence of vitamin A deficiency
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Roshini Claire Anthony, 24 Feb 2021

Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) did not result in worsening renal function or bone mineral density (BMD) in Asian patients with chronic hepatitis B virus (HBV) infection, according to a small real-world prospective study.

Roshini Claire Anthony, 6 days ago

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.